Jane Street Group, LLC Halozyme Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $682,290 - $856,786	13,300 New	13,300 $760,000
Q1 2022 May 17, 2022	SELL	$31.97 - $41.06 $262,154 - $336,692	-8,200 Reduced 30.94%	18,300 $730,000
Q4 2021 Feb 15, 2022	BUY	$31.82 - $40.75 $292,744 - $374,900	9,200 Added 53.18%	26,500 $1.07 Million
Q3 2021 Nov 16, 2021	BUY	$38.47 - $46.42 $230,820 - $278,520	6,000 Added 53.1%	17,300 $704,000
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $34,956 - $46,179	-900 Reduced 7.38%	11,300 $513,000
Q1 2021 May 18, 2021	SELL	$39.51 - $51.45 $181,746 - $236,670	-4,600 Reduced 27.38%	12,200 $509,000
Q4 2020 Feb 17, 2021	BUY	$25.81 - $43.62 $103,240 - $174,480	4,000 Added 31.25%	16,800 $718,000
Q3 2020 Nov 17, 2020	SELL	$25.74 - $29.63 $445,302 - $512,599	-17,300 Reduced 57.48%	12,800 $336,000
Q2 2020 Aug 17, 2020	BUY	$16.25 - $26.81 $489,125 - $806,981	30,100 New	30,100 $807,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.